Medicine review at the federal level sits with the US Food and Drug Administration, or FDA.
Agree who takes the next question
Ask who reviews your progress, how you send a concern and what happens if the named clinician is away. Keep the plan with your other care notes, ready for the day a question comes up.
- What is the next review meant to assess?
- Who explains any test result?
- How do I get care in person if it becomes necessary?
- What is the route for a medicine question and for a billing question?
A delivery problem belongs with the pharmacy
Georgia’s mail-order rules checked September 28, 2026 require a way to report medicine arriving late, damaged or different from what was ordered.
The storage guidance checked September 17, 2026 differs by product; it does not say that every peptide medicine needs to stay cold.
Semaglutide is among the weight or diabetes medicines called GLP-1 drugs, which act like a body messenger involved in blood sugar and appetite.
For an injectable GLP-1 medicine arriving warm or poorly refrigerated, the FDA source checked September 17, 2026 advises against use.
Ask the pharmacist about the exact product and its arrival condition.
Use the right route for an unresolved concern
As checked September 28, 2026, Georgia’s medical board takes concerns about doctors and physician assistants; it does not settle disputes over bills.
Pharmacy complaints go to Georgia’s pharmacy board; nurse complaints go through the nursing licensing office.
Keep the label, written plan, messages and bill so the concern is clear. The source file has the board complaint routes.
Open the help and complaint sources